Skip to content

A clinical study to evaluate the efficacy of Panchnimba Churna & Jalaukavcharna in the management of Dadru Kushtha

A clinical study to evaluate the efficacy of Panchnimba Churna & Jalaukavcharna in the management of Dadru Kushtha W.S.R. to Tinea Corporis - Nil

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108375
Enrollment
60
Registered
2026-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

SHRI DHANWANTRI Ayurvedic Medical College Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with classical Lakshanas of Dadru Kushtha W.S.R. Tinea Corporis Individuals between age group 18-50 Years either several. Chronicity of disease less than 6 months

Exclusion criteria

Exclusion criteria: Patients with age less than 18 years and more than 50 years Pregnant and breastfeeding women Patient with loose stools, stomach- upset, bloating Patient with other skin disease or major systemic illness Patient with lifestyle disorders Diabetes mellitus, Hypertension HIV or any immunocompromised patient. Patient with any malignant condition.

Design outcomes

Primary

MeasureTime frame
The following parameters were assessed during trial and follow Up Subjective improvement Objective improvement Investigation - Complete Blood CountTimepoint: 12 weeks

Secondary

MeasureTime frame
A suitable treatment option for Dadru will be established on the basis of primary outcome.Timepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Saurabh Parauha

SHRI DHANWANTRI Ayurvedic Medical College & Research Centre

sparauha5@gmail.com7067544816

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026